Taiwan FDA registration 96d7e2efd50f8486e47107bdfc4a30f9
"Leison Biotech" Glucose Control Solution (Non-Sterile)
TW: "連陞生技" 葡萄糖品管液(未滅菌)
Taiwan·Risk Class 1·MD·BIONOSTICS INC.·Registered Mar 31, 2021 – Mar 31, 2026ExpiredRegistration details
- Analysis ID
- 96d7e2efd50f8486e47107bdfc4a30f9
- License Form
- Ministry of Health Medical Device Import No. 022431
- Customs Code
- DHA09402243109
Company information
- Manufacturer
- BIONOSTICS INC.
- Manufacturer Country
- United States
- Authorized Representative
- LEISON BIOTECH CO., LTD.
Product details
- Intended Use
- Limited to the first level identification range of quality control materials (analytical and non-analytical) (A.1660) of the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Mar 31, 2021
- Expiry Date
- Mar 31, 2026
About this record
Access comprehensive regulatory information for "Leison Biotech" Glucose Control Solution (Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 96d7e2efd50f8486e47107bdfc4a30f9 and manufactured by BIONOSTICS INC.. The authorized representative in Taiwan is LEISON BIOTECH CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices